Lorraine Z. Mutsvunguma

AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region

Fiona T. van den Berg, Stuart A. Ali, Tristan Scott et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 43 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits

Gabriela M. Escalante, Joslyn Foley, Lorraine Z. Mutsvunguma et al. · Vaccines · 2020 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits

David H. Mulama, Lorraine Z. Mutsvunguma, Jennifer Totonchy et al. · Vaccine · 2019 · 33 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes

Lorraine Z. Mutsvunguma, Esther Rodríguez, Gabriela M. Escalante et al. · Virology · 2019 · 28 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types

Murali Muniraju, Lorraine Z. Mutsvunguma, Joslyn Foley et al. · Journal of Virology · 2019 · 26 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15